IGC Pharma (IGC) vs NextCure (NXTC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
NextCure (NXTC) has outperformed IGC Pharma (IGC) over the past year, gaining 7.1% versus a loss of 31.7%. Over five years, IGC leads with a -80.8% price change compared with -93.7% for NXTC. NextCure is the larger company by market cap ($29.9 million vs $29.0 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | IGC | NXTC |
|---|---|---|
| Share price | $0.2801 | $6.54 |
| Market cap | $28.96M | $29.91M |
| 1-day change | +0.04% | -0.38% |
| YTD return | 0.00% | -53.77% |
| 1-year return | -31.71% | +7.07% |
| 5-year return | -80.82% | -93.74% |
| EPS (TTM) | $-0.07 | $-8.71 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $0.45 | $15.74 |
| 52-week low | $0.24 | $1.55 |
| Distance from 52-week high | -37.76% | -58.48% |
| Average volume | 710.47K | 2.11M |
| Shares outstanding | 103.38M | 4.58M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- NXTC has outperformed IGC by 38.8 percentage points over the past year.
IGC vs NXTC FAQ
Which is bigger, IGC Pharma or NextCure?
NextCure (NXTC) is larger, with a market capitalization of $29.91M compared with $28.96M for IGC Pharma (IGC).
Which stock has performed better over the past year, IGC or NXTC?
NXTC returned +7.07% over the past 12 months, compared with -31.71% for IGC (price return, excluding dividends). Past performance does not predict future results.
Are IGC Pharma and NextCure in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.